Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
2.200
-0.130 (-5.58%)
At close: Nov 21, 2024, 4:00 PM
2.370
+0.170 (7.73%)
After-hours: Nov 21, 2024, 4:10 PM EST
Rockwell Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 98.92 | 83.61 | 72.81 | 61.93 | 62.2 | 61.3 | Upgrade
|
| Revenue Growth (YoY) | 22.37% | 14.84% | 17.57% | -0.43% | 1.46% | -3.29% | Upgrade
|
| Cost of Revenue | 82.19 | 74.91 | 68.73 | 64.35 | 59.47 | 58.46 | Upgrade
|
| Gross Profit | 16.72 | 8.7 | 4.08 | -2.42 | 2.73 | 2.84 | Upgrade
|
| Selling, General & Admin | 15.96 | 14.27 | 17.74 | 21.08 | 24.05 | 30.05 | Upgrade
|
| Research & Development | 0.19 | 1.11 | 3.12 | 6.84 | 7.09 | 6.89 | Upgrade
|
| Operating Expenses | 16.14 | 15.37 | 20.86 | 27.92 | 31.15 | 36.93 | Upgrade
|
| Operating Income | 0.58 | -6.67 | -16.78 | -30.34 | -28.42 | -34.1 | Upgrade
|
| Interest Expense | -2.07 | -2.3 | -1.94 | -2.36 | -1.88 | -0.03 | Upgrade
|
| Interest & Investment Income | 0.11 | 0.21 | 0.03 | 0.02 | 0.24 | 0.39 | Upgrade
|
| EBT Excluding Unusual Items | -1.39 | -8.76 | -18.68 | -32.67 | -30.06 | -33.73 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.15 | 0.32 | 0 | - | 0.01 | 0.03 | Upgrade
|
| Legal Settlements | - | - | - | - | - | -0.43 | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.84 | - | Upgrade
|
| Pretax Income | -1.24 | -8.44 | -18.68 | -32.67 | -30.89 | -34.13 | Upgrade
|
| Net Income | -1.24 | -8.44 | -18.68 | -32.67 | -30.89 | -34.13 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.15 | 0.15 | - | - | - | - | Upgrade
|
| Net Income to Common | -1.39 | -8.59 | -18.68 | -32.67 | -30.89 | -34.13 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 23 | 14 | 9 | 7 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 23 | 14 | 9 | 7 | 6 | Upgrade
|
| Shares Change (YoY) | 57.66% | 63.05% | 67.77% | 24.02% | 24.14% | 15.32% | Upgrade
|
| EPS (Basic) | -0.05 | -0.37 | -1.31 | -3.83 | -4.49 | -6.16 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.37 | -1.31 | -3.83 | -4.49 | -6.16 | Upgrade
|
| Free Cash Flow | - | -9.7 | -17.21 | -34.06 | -30.69 | -27.84 | Upgrade
|
| Free Cash Flow Per Share | - | -0.42 | -1.20 | -3.99 | -4.46 | -5.03 | Upgrade
|
| Gross Margin | 16.91% | 10.41% | 5.60% | -3.91% | 4.38% | 4.63% | Upgrade
|
| Operating Margin | 0.59% | -7.98% | -23.05% | -48.98% | -45.69% | -55.62% | Upgrade
|
| Profit Margin | -1.40% | -10.27% | -25.65% | -52.76% | -49.66% | -55.67% | Upgrade
|
| Free Cash Flow Margin | - | -11.60% | -23.64% | -54.99% | -49.34% | -45.42% | Upgrade
|
| EBITDA | 2.78 | -5.23 | -16.2 | -29.67 | -27.59 | -33.31 | Upgrade
|
| EBITDA Margin | 2.81% | -6.25% | -22.26% | -47.90% | -44.35% | -54.33% | Upgrade
|
| D&A For EBITDA | 2.2 | 1.44 | 0.58 | 0.67 | 0.83 | 0.79 | Upgrade
|
| EBIT | 0.58 | -6.67 | -16.78 | -30.34 | -28.42 | -34.1 | Upgrade
|
| EBIT Margin | 0.59% | -7.98% | -23.05% | -48.98% | -45.69% | -55.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.